Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_assertion description "[The oncogenic potential and apparent absence of physiologic defects in adult human tissues lacking GPR56, as well as the targetable nature of G protein - coupled receptor by small molecule or antibody, make GPR56 an attractive drug target for the development of cancer therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_assertion evidence source_evidence_literature NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_assertion SIO_000772 17575113 NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_assertion wasDerivedFrom befree-20140225 NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_assertion wasGeneratedBy ECO_0000203 NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP500821.RAnMd9AGuw1L3SLQNxImB3R-Xsgy_a2uMjDJyYLEX-DXU130_provenance.